Chevy Chase Trust’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-288,321
| Closed | -$3.36M | – | 645 |
|
|
2024
Q4 | $3.36M | Sell |
288,321
-522,712
| -64% | -$8.16M | 0.01% | 544 |
|
|
2024
Q3 | $16.7M | Sell |
811,033
-231,592
| -22% | -$5.34M | 0.05% | 305 |
|
|
2024
Q2 | $23.3M | Sell |
1,042,625
-31,985
| -3% | -$762K | 0.07% | 216 |
|
|
2024
Q1 | $29.6M | Buy |
1,074,610
+83,435
| +8% | +$2.32M | 0.1% | 186 |
|
|
2023
Q4 | $30.2M | Sell |
991,175
-11,780
| -1% | -$339K | 0.11% | 172 |
|
|
2023
Q3 | $31.7M | Buy |
1,002,955
+29,412
| +3% | +$1.14M | 0.13% | 153 |
|
|
2023
Q2 | $39.7M | Buy |
973,543
+36,477
| +4% | +$1.48M | 0.15% | 135 |
|
|
2023
Q1 | $34.9M | Sell |
937,066
-35,010
| -4% | -$1.37M | 0.14% | 144 |
|
|
2022
Q4 | $33.9M | Sell |
972,076
-165,399
| -15% | -$7.86M | 0.14% | 143 |
|
|
2022
Q3 | $63.7M | Buy |
1,137,475
+101,170
| +10% | +$6.28M | 0.27% | 88 |
|
|
2022
Q2 | $53.6M | Sell |
1,036,305
-20,463
| -2% | -$1.04M | 0.22% | 99 |
|
|
2022
Q1 | $76.8M | Sell |
1,056,768
-81,336
| -7% | -$6.89M | 0.26% | 89 |
|
|
2021
Q4 | $135M | Sell |
1,138,104
-20,628
| -2% | -$2.58M | 0.43% | 49 |
|
|
2021
Q3 | $155M | Sell |
1,158,732
-87,839
| -7% | -$13.3M | 0.54% | 35 |
|
|
2021
Q2 | $202M | Sell |
1,246,571
-77,858
| -6% | -$6.06M | 0.69% | 26 |
|
|
2021
Q1 | $106M | Sell |
1,324,429
-311,443
| -19% | -$20.9M | 0.38% | 58 |
|
|
2020
Q4 | $89M | Sell |
1,635,872
-168,384
| -9% | -$6.11M | 0.32% | 75 |
|
|
2020
Q3 | $35.9M | Buy |
1,804,256
+246,093
| +16% | +$5.13M | 0.14% | 152 |
|
|
2020
Q2 | $32.8M | Buy |
1,558,163
+173,351
| +13% | +$2.94M | 0.13% | 161 |
|
|
2020
Q1 | $16.9M | Buy |
1,384,812
+51,987
| +4% | +$700K | 0.08% | 237 |
|
|
2019
Q4 | $19.6M | Buy |
1,332,825
+78,058
| +6% | +$1.09M | 0.07% | 265 |
|
|
2019
Q3 | $16.8M | Buy |
1,254,767
+154,922
| +14% | +$2.47M | 0.07% | 287 |
|
|
2019
Q2 | $18M | Buy |
1,099,845
+143,334
| +15% | +$2.25M | 0.07% | 274 |
|
|
2019
Q1 | $14.7M | Buy |
956,511
+261,175
| +38% | +$3.89M | 0.06% | 320 |
|
|
2018
Q4 | $9.49M | Sell |
695,336
-46,688
| -6% | -$868K | 0.05% | 379 |
|
|
2018
Q3 | $21.2M | Buy |
742,024
+86,142
| +13% | +$2.51M | 0.09% | 237 |
|
|
2018
Q2 | $17.9M | Buy |
655,882
+67,714
| +12% | +$1.64M | 0.08% | 270 |
|
|
2018
Q1 | $12.4M | Buy |
+588,168
| New | +$14.5M | 0.06% | 357 |
|
Other funds holding NTLA
AIM
RP
NAMA